Popular diabetes medications may protect against Alzheimer’s disease, UF researchers find
Dr. Serena Jingchuan Guo is the senior author of a study published in JAMA Neurology April 7.
Posted in
Research
UF pharmacy professor’s paper ranks No. 2 in citations this century
A 2001 publication co-authored by Dr. Thomas Schmittgen has garnered nearly 150,000 citations in the Web of Science database, securing its place as the second most-cited research article of the 21st century, according to Nature.
Building a heart-healthy future: Cardio-Oncology Symposium cultivates innovative research
The UF Cardio-Oncology Symposium on April 3 provided an engaging forum to spark new research collaborations. The event showcased how innovations in precision medicine, early detection and multidisciplinary collaboration are directly enhancing patient care.
UF researchers identify safer pathway for pain relief
A new study published in Nature Communications outlines how UF scientists, including Dr. Jay McLaughlin, are developing safer and better pain medications.
UF researchers demonstrate GLP-1RAs’ potential to treat depression
A study led by Dr. Serena Jingchuan Guo may carry significant implications for older patients with diabetes.
Students demonstrate innovation and collaboration at 38th Annual Research Showcase
The Feb. 17 event saw 112 poster presentations and 12 oral presentations from UF pharmacy students and trainees.
Kratom science and policy take center stage at international symposium
Nearly 100 attendees from Southeast Asia, Europe, and North America participated in the Fourth International Kratom Symposium.
UF scientists discover key differences in male and female responses to stress in the brain
In a study published in Science Advances, UF College of Pharmacy researchers found key differences in the brain’s response to stress, unlocking the potential for personalized treatments for anxiety, depression, and stress-related disorders.
Research Snapshot: Researchers identify genes that predict pediatric AML outcomes
UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.
UF, Micro-gRx, and Ronawk collaborate on translational research in advanced tissue engineering aboard the International Space Station
The National Science Foundation and the Center for the Advancement of Science in Space have awarded $830,000 to the University of Florida, Micro-gRx, and Ronawk to launch an innovative tissue engineering experiment into space.
